Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth.

阅读:3
作者:Stoltz David A, Meyerholz David K, Pezzulo Alejandro A, Ramachandran Shyam, Rogan Mark P, Davis Greg J, Hanfland Robert A, Wohlford-Lenane Chris, Dohrn Cassie L, Bartlett Jennifer A, Nelson George A 4th, Chang Eugene H, Taft Peter J, Ludwig Paula S, Estin Mira, Hornick Emma E, Launspach Janice L, Samuel Melissa, Rokhlina Tatiana, Karp Philip H, Ostedgaard Lynda S, Uc Aliye, Starner Timothy D, Horswill Alexander R, Brogden Kim A, Prather Randall S, Richter Sandra S, Shilyansky Joel, McCray Paul B Jr, Zabner Joseph, Welsh Michael J
Lung disease causes most of the morbidity and mortality in cystic fibrosis (CF). Understanding the pathogenesis of this disease has been hindered, however, by the lack of an animal model with characteristic features of CF. To overcome this problem, we recently generated pigs with mutated CFTR genes. We now report that, within months of birth, CF pigs spontaneously developed hallmark features of CF lung disease, including airway inflammation, remodeling, mucus accumulation, and infection. Their lungs contained multiple bacterial species, suggesting that the lungs of CF pigs have a host defense defect against a wide spectrum of bacteria. In humans, the temporal and causal relations between inflammation and infection have remained uncertain. To investigate these processes, we studied newborn pigs. Their lungs showed no inflammation but were less often sterile than controls. Moreover, after introduction of bacteria into their lungs, pigs with CF failed to eradicate bacteria as effectively as wild-type pigs. These results suggest that impaired bacterial elimination is the pathogenic event that initiates a cascade of inflammation and pathology in CF lungs. Our finding that pigs with CF have a host defense defect against bacteria within hours of birth provides an opportunity to further investigate CF pathogenesis and to test therapeutic and preventive strategies that could be deployed before secondary consequences develop.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。